Symbicort Patient Tips
Medically reviewed on Nov 23, 2017 by C. Fookes, BPharm.
How it works
- Symbicort is a combination inhaler containing budesonide and formoterol. Budesonide is a corticosteroid that decreases inflammation. When it is used in an inhaler, it specifically and generally only decreases inflammation in the lungs and airways. Budesonide belongs to the class of medicines known as inhaled corticosteroids (ICS). It is specifically a glucocorticoid.
- Formoterol is a long-acting bronchodilator. Formoterol relaxes muscles in the airways which allows them to open, making breathing easier. Formoterol belongs to the class of medicines known as long-acting beta2-adrenergic agonists (LABA).
- Symbicort belongs to the class of medicines known as combination LABA/ICS inhalers.
- May be used in the treatment of moderate-to-severe asthma in adults and children over the age of six years.
- A specific strength of Symbicort (160/4.5) may be used as a maintenance treatment in people with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema, to reduce inflammation and airflow obstruction.
- Having two medications in one inhaler is more convenient than having to take two inhalers.
- Having these medications in an inhaled form means they work directly where they need to with less risk of side effects.
If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include:
- Throat irritation, sinusitis, nasopharyngitis (runny or stuffy nose, sneezing), headache, oral thrush, upper and lower respiratory tract infections, and stomach discomfort.
- Other side effects that are uncommon but may be associated with Symbicort include cataracts, glaucoma, and other eye problems; low potassium levels; and an increase in blood glucose levels.
- Symbicort does not relieve acute bronchospasm (breathlessness). Although formoterol does open the airways, it takes time to work and Symbicort should never be used for the emergency treatment of asthma. A rescue inhaler, such as albuterol, should always be kept close by to treat sudden symptoms.
- LABAs, such as formoterol, one of the ingredients in Symbicort, have been associated with an increased risk of asthma-related deaths. It is not known whether concurrent use of inhaled corticosteroids (such as budesonide - also contained in Symbicort) mitigates this risk. For this reason, Symbicort is generally only recommended for people with asthma not adequately controlled with an inhaled corticosteroid or with a disease severity that warrants the addition of an LABA. Even once initiated, the need for continued Symbicort based on asthma control should be reassessed at regular intervals by a doctor.
- May not be suitable for people with certain types of heart disease. Rarely, formoterol has been associated with pulse rate and blood pressure increases and ECG changes.
- Corticosteroids, such as budesonide, may increase your risk of developing pneumonia or increase the severity of viral infections such as chickenpox and measles. Always make sure you keep your recommended vaccines up to date.
- Symbicort may interact with several drugs such as ketoconazole, HIV medications, antidepressants, glaucoma treatments, and clarithromycin.
- Long-term administration of corticosteroids, such as budesonide, is associated with a reduction in bone mineral density. It is not known if this is related to an increase in fracture risk. The risk is greatest in those who are immobile, post-menopausal, with a family history of osteoporosis, who smoke, with a poor diet, or who take other drugs that also reduce bone mass (such as anticonvulsants or oral corticosteroids).
- Regular administration of corticosteroids, such as budesonide, has been associated with a reduction in growth velocity in children. Growth rates should be monitored if Symbicort is used in children.
- There is currently no FDA-approved generic version of Symbicort.
Notes: In general, seniors or children, people with certain medical conditions (such as liver or kidney problems, heart disease, diabetes, seizures) or people who take other medications are more at risk of developing a wider range of side effects. For a complete list of all side effects, click here.
- Inhale Symbicort exactly as directed by your doctor. The usual dosage is two inhalations, morning and night (12 hours apart). Do not exceed the recommended dose as potentially fatal side effects are more likely.
- If you develop asthma symptoms in the time between Symbicort dosages, use a short-acting inhaled, beta2-agonist such as albuterol to relieve breathlessness.
- Rinse the mouth out with water following a dose of Symbicort, then spit the water out (do not swallow). Doing this reduces the risk of oral thrush developing.
- If you are using Symbicort for the first time, or if it has been dropped or not used for seven days, you will need to prime it. Shake the inhaler well for five seconds then release a test spray. Repeat this process, making sure you point the inhaler in a safe direction and away from the face.
- Symbicort is available as two different strengths: budesonide 80mcg and formoterol 4.5mcg and budesonide 160mcg and formoterol 4.5mcg. Always make sure you are using the correct strength as prescribed by your doctor.
- If Symbicort appears to make you more breathless, stop taking it. Inhale a dose of your short-acting bronchodilator instead (such as albuterol, and tell your doctor immediately.
- Always let other health professionals know that you are taking Symbicort. Do not take any other medications, including those bought over-the-counter, before checking that they are compatible with Symbicort.
Response and Effectiveness
- The effectiveness of Symbicort depends on regular usage. An improvement in asthma control may be seen within 15 minutes of treatment; however, it may take up to two weeks before the full benefits are seen. Response times and degree of effectiveness can vary from person to person.
- Orally inhaled budesonide is rapidly absorbed in the lungs and peak concentrations are usually reached within 20 minutes.
- Formoterol in a powdered form (as used for inhalation) starts to work within 3 minutes and 80% of the peak effect occurs within 15 minutes. Effects last approximately 12 hours in most people.
Symbicort [Package Insert]. Revised 01/2017. AstraZeneca Pharmaceuticals LP https://www.drugs.com/pro/symbicort.html
More about Symbicort (budesonide / formoterol)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 110 Reviews – Add your own review/rating
- Drug class: bronchodilator combinations
- Symbicort inhalation
- Symbicort (Advanced Reading)
- Symbicort 100 Turbuhaler (Advanced Reading)
- Symbicort 200 Turbuhaler (Advanced Reading)
Related treatment guides
- Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Symbicort only for the indication prescribed.
- Disclaimer: Every effort has been made to ensure that this information is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This drug information does not endorse drugs, diagnose patients or recommend therapy. It is an informational resource designed as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of this information. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2018 Drugs.com. Revision Date: 2017-11-22 22:34:30